In Lithuania, the Insulin market size value per capita increased from $13.8 in 2013 to $17.14 in 2017, indicating a notable rise. However, fluctuations followed, with 2023 observing a decline to $12.65 per capita. Reviewing the year-on-year variation, there was a minor decrease from 2022 to 2023, continuing a downward trend that started from 2018 except for intermittent fluctuations. Over the past five years, a negative compound annual growth rate (CAGR) is seen as the market contracted.
Looking ahead, factors such as innovative insulin delivery systems, growing diabetic populations, and healthcare reforms could influence per capita consumption positively. Technological advancements and economic stability might further shape market dynamics.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 13 | 13 Slovakia | 13.6 | 2023 | View data | ||
| 14 | 14 Japan | 13.48 | 2023 | View data | ||
| 15 | 15 Lithuania | 12.65 | 2023 | |||
| 16 | 16 Ireland | 11.52 | 2023 | View data | ||
| 17 | 17 Austria | 10.77 | 2023 | View data | ||
